Related Experiment Video
Updated: May 13, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
Silver-based nanoparticles induce apoptosis in human colon cancer cells mediated through p53
Shakti Ranjan Satapathy1, Purusottam Mohapatra, Ranjan Preet
1Cancer Biology Division, KIIT School of Biotechnology, KIIT University, Campus-11, Patia, Bhubaneswar, Orissa 751024, India.
Aim:
The authors have systematically investigated the anticancer potentiality of silver-based nanoparticles (AgNPs) and the mechanism underlying their biological activity in human colon cancer cells.
Materials & Methods:
Starch-capped AgNPs were synthesized, characterized and their biological activity evaluated through multiple biochemical assays.
Results:
AgNPs decreased the growth and viability of HCT116 colon cancer cells. AgNP exposure increased apoptosis, as demonstrated by an increase in 4´,6-diamidino-2-phenylindole-stained apoptotic nuclei, BAX/BCL-XL ratio, cleaved poly(ADP-ribose) polymerase, p53, p21 and caspases 3, 8 and 9, and by a decrease in the levels of AKT and NF-κB. The cell population in the G1 phase decreased, and the S-phase population increased after AgNP treatment. AgNPs caused DNA damage and reduced the interaction between p53 and NF-κB. Interestingly, no significant alteration was noted in the levels of p21, BAX/BCL-XL and NF-κB after AgNP treatment in a p53-knockout HCT116 cell line.
Conclusion:
AgNPs are bona fide anticancer agents that act in a p53-dependent manner. Original submitted 16 March 2012; Revised submitted 25 August 2012; Published online 21 March 2013.
Insights
Silver-based nanoparticles (AgNPs) show anticancer potential by inducing apoptosis and DNA damage in colon cancer cells. Their efficacy is dependent on the p53 tumor suppressor protein.
Area of Science:
- Nanotechnology
- Oncology
- Molecular Biology
Background:
- Silver-based nanoparticles (AgNPs) are being explored for their therapeutic potential.
- Understanding the mechanisms of AgNPs' biological activity is crucial for developing new cancer treatments.
Purpose of the Study:
- To investigate the anticancer effects of AgNPs in human colon cancer cells.
- To elucidate the molecular mechanisms underlying AgNP-induced cytotoxicity.
Main Methods:
- Synthesis and characterization of starch-capped AgNPs.
- Evaluation of AgNP biological activity using biochemical assays in HCT116 colon cancer cells.
- Analysis of apoptosis markers, cell cycle progression, DNA damage, and key signaling pathways (p53, AKT, NF-κB).
Main Results:
- AgNPs significantly reduced colon cancer cell growth and viability.
- AgNP treatment induced apoptosis, increased DNA damage, and altered cell cycle distribution.
- The anticancer effects were mediated through p53-dependent pathways, involving modulation of BAX/BCL-XL ratio, caspases, AKT, and NF-κB signaling.
Conclusions:
- AgNPs demonstrate significant anticancer properties against colon cancer cells.
- The mechanism of action is p53-dependent, highlighting the role of this tumor suppressor in AgNP-induced cell death.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
